CLINICAL_TRIALS
trial_result
· 2014-04-16
Clinical Trial Update: Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis [Phase 3]
Summary
Phase 3 trial evaluating safety and effectiveness of AZLI (aztreonam for inhalation) in adults with bronchiectasis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Bronchiectasis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-16